Medical treatment decisions are based on randomised clinical trials that rely on average group-level measurements. To determine the most suitable form of therapy that meets patients’ wishes and expectations with respect to their lifestyle and disease progression, physicians need to take patient characteristics into account. Advancements in the area of Artificial Intelligence (AI), Machine Learning (ML) and the establishment of national databases over the last decades now enable such personalised medicine approaches.
We combine our industry knowledge in pharma and healthcare, brand independence, and a unique set of data analytics capabilities to develop personalised healthcare solutions with prognostic and predictive accuracy for patients with neurological disorders.
Personalised healthcare solutions that use AI algorithms and are based on the authentic data of thousands of patients make choosing a suitable treatment for physicians both safer and more transparent.
Christian B. Westermann
Partner and Leader Data and Analytics, PwC Switzerland
Tel: +41 58 792 27 97
Philip van Hövell
Health Analytics Leader, Data and Analytics, PwC Switzerland
Tel: +41 58 792 10 76